TriangleFOR PATIENTS · SOURCE READING
Treatment of Metastatic and Recurrent Laryngeal Cancer
Source: Laryngeal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
For information about the treatments listed below, see the Treatment Option Overview section.
Source links and citations
Treatment of metastatic and recurrent laryngeal cancer may include the following:
Source links and citations
Surgery with or without radiation therapy.
Source links and citations
Radiation therapy.
Chemotherapy.
Source links and citations
Immunotherapy with pembrolizumab or nivolumab.
Source links and citations
A clinical trial of a new treatment.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice